ES2310907T3 - Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol. - Google Patents

Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol. Download PDF

Info

Publication number
ES2310907T3
ES2310907T3 ES06706961T ES06706961T ES2310907T3 ES 2310907 T3 ES2310907 T3 ES 2310907T3 ES 06706961 T ES06706961 T ES 06706961T ES 06706961 T ES06706961 T ES 06706961T ES 2310907 T3 ES2310907 T3 ES 2310907T3
Authority
ES
Spain
Prior art keywords
dienogest
content
medication
delayed
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06706961T
Other languages
English (en)
Spanish (es)
Inventor
Sabine Fricke
Hagen Gerecke
Ralf Ladwig
Alexander Buske
Harald Rathe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jenapharm GmbH and Co KG
Original Assignee
Jenapharm GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05003181A external-priority patent/EP1690529A1/de
Priority claimed from EP05003179A external-priority patent/EP1690543A1/de
Application filed by Jenapharm GmbH and Co KG filed Critical Jenapharm GmbH and Co KG
Application granted granted Critical
Publication of ES2310907T3 publication Critical patent/ES2310907T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
ES06706961T 2005-02-15 2006-02-15 Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol. Expired - Lifetime ES2310907T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05003179 2005-02-15
EP05003181A EP1690529A1 (de) 2005-02-15 2005-02-15 Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
EP05003181 2005-02-15
EP05003179A EP1690543A1 (de) 2005-02-15 2005-02-15 Pharmazeutisches Präparat zur Kontrazeption

Publications (1)

Publication Number Publication Date
ES2310907T3 true ES2310907T3 (es) 2009-01-16

Family

ID=37951746

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06706961T Expired - Lifetime ES2310907T3 (es) 2005-02-15 2006-02-15 Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol.

Country Status (20)

Country Link
EP (1) EP1848406B1 (pl)
JP (1) JP2008527019A (pl)
KR (1) KR20070087141A (pl)
AT (1) ATE395047T1 (pl)
AU (1) AU2006215822B2 (pl)
BR (1) BRPI0606297A2 (pl)
CA (1) CA2594939A1 (pl)
CY (1) CY1108265T1 (pl)
DE (1) DE502006000771D1 (pl)
DK (1) DK1848406T3 (pl)
EA (1) EA200701389A1 (pl)
ES (1) ES2310907T3 (pl)
HR (1) HRP20080394T3 (pl)
IL (1) IL184257A0 (pl)
NO (1) NO20072893L (pl)
PL (1) PL1848406T3 (pl)
PT (1) PT1848406E (pl)
RS (1) RS50597B (pl)
SI (1) SI1848406T1 (pl)
WO (1) WO2006087177A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009015766A1 (de) * 2007-07-31 2009-02-05 Bayer Schering Pharma Aktiengesellschaft Einphasisches pharmazeutisches kombinationspräparat (dienogest und ethinylestradiol) zur oralen therapie der regulierung des blutdruckes
RU2009135418A (ru) * 2007-07-31 2011-09-10 Байер Шеринг Фарма Акциенгезельшафт (DE) Однофазный фармацевтический композитный препарат (диеногеста и этинилэстрадиола) для пероральной терапии для регулирования артериального давления
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤
EP3954364A1 (en) 2020-08-14 2022-02-16 Chemo Research, S.L. New modified release oral contraceptive composition
KR102652671B1 (ko) 2023-12-26 2024-03-29 주식회사 스몰랩 피임 마이크로니들용 미립구 조성물 및 이를 포함한 피임 마이크로니들
US20260021110A1 (en) 2024-07-18 2026-01-22 Chemo Research, S.L. Methods of oral contraception by controlled release of dienogest and ethynyl estradiol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält

Also Published As

Publication number Publication date
RS50597B (sr) 2010-05-07
CY1108265T1 (el) 2014-02-12
SI1848406T1 (sl) 2008-10-31
NO20072893L (no) 2007-09-12
EA200701389A1 (ru) 2008-02-28
PL1848406T3 (pl) 2009-06-30
CA2594939A1 (en) 2006-08-24
BRPI0606297A2 (pt) 2009-06-09
EP1848406A2 (de) 2007-10-31
WO2006087177A3 (de) 2007-08-30
DE502006000771D1 (de) 2008-06-26
WO2006087177B1 (de) 2007-10-11
IL184257A0 (en) 2007-10-31
JP2008527019A (ja) 2008-07-24
WO2006087177A8 (de) 2007-05-24
HRP20080394T3 (hr) 2008-11-30
AU2006215822A1 (en) 2006-08-24
EP1848406B1 (de) 2008-05-14
WO2006087177A2 (de) 2006-08-24
KR20070087141A (ko) 2007-08-27
ATE395047T1 (de) 2008-05-15
DK1848406T3 (da) 2008-09-15
PT1848406E (pt) 2008-08-21
AU2006215822B2 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
US11957694B2 (en) Orodispersible dosage unit containing an estetrol component
JP6813150B2 (ja) エステトロールを含有する口腔内崩壊錠
CA3003062C (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
JP6866561B2 (ja) エステトロールを含有する口腔内崩壊錠
JP6866560B2 (ja) エステトロール成分を含有する口腔内崩壊性投与単位
CN101637462B (zh) 结合雌激素组合物以及相关方法
ES2310907T3 (es) Forma de medicamento peroral solida para la contracepcion, que contiene dienogest y etinilestradiol.
BRPI0513938B1 (pt) composição farmacêutica contendo drospirenona e etinilestradiol
TW200904452A (en) New drospirenone/17β-estradiol regimen, pharmaceutical combination, product and kit for performing this regimen
HK1207588A1 (en) Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
ES2327665T3 (es) Forma medicamentosa peroral con dienogest y etinilestradiol para la contracepcion.
EP1690529A1 (de) Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
US20060205701A1 (en) Solid peroral contraceptive preparations
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
US20070072836A1 (en) Solid peroral contraceptive preparations
OA18501A (en) Orodispersible dosage unit containing an estetrol component.
BR112017027211B1 (pt) Unidade de dosagem orodispersível contendo componente estetrol, processo de preparação e uso da mesma